De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Afya Beheer

Beheer criteriumcontroles 2/4

De CEO Afya's is Virgilio Deloy Gibbon, benoemd in Jul2019, heeft een ambtstermijn van 5.25 jaar. bezit rechtstreeks 0.43% van de aandelen van het bedrijf, ter waarde $ 6.60M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 5.3 jaar en 4.2 jaar.

Belangrijke informatie

Virgilio Deloy Gibbon

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO5.3yrs
Eigendom CEO0.4%
Management gemiddelde ambtstermijn5.3yrs
Gemiddelde ambtstermijn bestuur4.2yrs

Recente managementupdates

Recent updates

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Aug 29

Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Aug 29
Here's Why Afya (NASDAQ:AFYA) Has Caught The Eye Of Investors

Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Aug 15
Is It Time To Consider Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Jul 17
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Jun 20
Afya Limited (NASDAQ:AFYA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Afya's Results Are Improving And The Market Is Undervaluing It

Jun 06

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

May 14
Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

AFYA: Mr Market Is Mistaken

Apr 29

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Apr 27
Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Apr 09
Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Mar 19

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Mar 17
Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Feb 10
Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Jan 21
Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Jan 03
Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Dec 07
These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Nov 02
Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Sep 20
What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Aug 17
Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Aug 23

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Jul 28

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Apr 14

Afya On A Grey Price Area

Dec 25

Afya: The Longer-Term Growth Story Remains Intact

Sep 19

Afya to acquire UNIGRANRIO for R$700M

May 27

Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Apr 04
Here's Why I Think Afya (NASDAQ:AFYA) Is An Interesting Stock

Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Mar 09
Is Afya Limited's (NASDAQ:AFYA) ROE Of 11% Impressive?

Is Afya (NASDAQ:AFYA) Using Too Much Debt?

Feb 16
Is Afya (NASDAQ:AFYA) Using Too Much Debt?

A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

Jan 29
A Look At The Intrinsic Value Of Afya Limited (NASDAQ:AFYA)

The Trends At Afya (NASDAQ:AFYA) That You Should Know About

Jan 12
The Trends At Afya (NASDAQ:AFYA) That You Should Know About

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24
What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Afya BOD approves share buyback program

Dec 23

Afya reports Q3 results

Dec 03

Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Dec 03
Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

CEO

Virgilio Deloy Gibbon (48 yo)

5.3yrs

Tenure

Mr. Virgilio Deloy Capobianco Gibbon is Chief Executive Officer of Afya Limited since July 2019. He has been the Chief Executive Officer of Afya Brazil since August 2016. Prior to joining us, he was Chief...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Virgilio Deloy Gibbon
Chief Executive Officer5.3yrsgeen gegevens0.43%
R$ 6.7m
Luis Andre Blanco
Chief Financial Officer4.5yrsgeen gegevens0.047%
R$ 728.6k
Renata Couto
Investor Relations Executive Managerno datageen gegevensgeen gegevens
Julio Eduardo de Angeli
Vice President of Continuing Education & Innovation5.3yrsgeen gegevensgeen gegevens

5.3yrs

Gemiddelde duur

51yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van AFYA is doorgewinterd en ervaren (gemiddelde ambtstermijn van 5.3 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Kay Krafft
Co-Chairman3.2yrsgeen gegevensgeen gegevens
Maria Azevedo
Director2.5yrsgeen gegevensgeen gegevens
Vanessa Lopes
Independent Director5.3yrsgeen gegevens0.0015%
R$ 22.8k
Nicolau Esteves
Co-Chairman5.3yrsgeen gegevens18.67%
R$ 291.2m
Renato Esteves
Director5.3yrsgeen gegevens2.82%
R$ 44.0m
Miguel Filisbino De Paula
Independent Director4.2yrsgeen gegevensgeen gegevens
Joao Paulo De Faria
Independent Director4.2yrsgeen gegevensgeen gegevens
Christina Krebs
Director2.4yrsgeen gegevensgeen gegevens
Benedikt Dalkmann
Director2.4yrsgeen gegevensgeen gegevens
Marcelo Suhara
Independent Directorno datageen gegevensgeen gegevens

4.2yrs

Gemiddelde duur

48.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van AFYA wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).